Arkema Stock: Record Cash Flow and Declining EBITDA Stir Session Post Annual Results

Mixed Annual Accounts Unveiled

Arkema revealed on February 26 contrasting annual accounts. EBITDA amounted to 1,251 million euros, down 18% compared to the previous year, hampered by a challenging macroeconomic environment for the chemical sector. However, the group managed to generate a current cash flow of 464 million euros, significantly exceeding its revised forecasts. This performance reflects rigorous cost management and an ability to efficiently convert profitability into liquidity. This record result in cash generation marks a notable point in a year otherwise characterized by pressures on volumes and margins. On the same day, the group also faces several financial deadlines in the coming months, with the first-quarter results scheduled for May 6 and the general meeting set for May 21.

Technical Analysis of Stock Performance

Technically, Arkema's stock price is now well above its 50-day moving average at 54.72 euros, as well as its 200-day moving average at 57.15 euros. This double crossover confirms an upward trend in the short and medium term, with the stock having regained more than 17% in three months after a significant decline over the year (?24.52%). The RSI is positioned at 58, in a neutral zone that leaves room for progression before reaching the overbought zone, generally set beyond 70. The nearest resistance is at 65.45 euros, approximately 6.6% above the current price. This technical level could be a crucial milestone for the continuation of the upward movement that began since the end of last year.